Andra Ap Fonden Bristol Myers Squibb CO Transaction History

Andra Ap Fonden

$5.88 Billion
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$47.98 - $54.4 $48.9 Million - $55.4 Million	1,019,000 New	1,019,000 $55.3 Million
Q2 2023 Aug 09, 2023	BUY	$63.71 - $70.74 $3.34 Million - $3.71 Million	52,500 Added 38.02%	190,600 $12.2 Million
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $1.08 Million - $1.22 Million	16,400 Added 13.48%	138,100 $9.57 Million
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $3.47 Million - $4.11 Million	-50,700 Reduced 29.41%	121,700 $8.76 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $3,640 - $2.15 Million	-28,000 Reduced 13.97%	172,400 $12.3 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $944,060 - $1.04 Million	13,000 Added 6.94%	200,400 $15.4 Million
Q4 2021 Feb 15, 2022	SELL	$53.63 - $62.52 $289,602 - $337,608	-5,400 Reduced 2.8%	187,400 $11.7 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $1.01 Million - $1.19 Million	-17,100 Reduced 8.15%	192,800 $11.4 Million
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $4.1 Million - $4.46 Million	66,200 Added 46.07%	209,900 $14 Million
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $1.37 Million - $1.54 Million	23,100 Added 19.15%	143,700 $9.07 Million
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $28,870 - $32,715	-500 Reduced 0.41%	120,600 $7.48 Million
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $775,305 - $859,140	-13,500 Reduced 10.03%	121,100 $7.3 Million
Q2 2020 Aug 06, 2020	SELL	$54.82 - $64.09 $1.73 Million - $2.03 Million	-31,600 Reduced 19.01%	134,600 $7.91 Million
Q1 2020 May 13, 2020	BUY	$46.4 - $67.43 $213,440 - $310,178	4,600 Added 2.85%	166,200 $9.26 Million
Q4 2019 Feb 10, 2020	SELL	$49.21 - $64.19 $152,551 - $198,989	-3,100 Reduced 1.88%	161,600 $10.4 Million
Q3 2019 Nov 19, 2019	SELL	$42.77 - $50.71 $1.95 Million - $2.31 Million	-45,500 Reduced 21.65%	164,700 $8.35 Million
Q2 2019 Aug 15, 2019	BUY	$44.62 - $49.34 $709,458 - $784,506	15,900 Added 8.18%	210,200 $9.53 Million
Q1 2019 May 14, 2019	SELL	$45.12 - $53.8 $1.24 Million - $1.48 Million	-27,500 Reduced 12.4%	194,300 $9.27 Million
Q3 2018 Oct 16, 2018	SELL	$55.19 - $62.25 $629,166 - $709,650	-11,400 Reduced 4.89%	221,800 $13.8 Million
Q2 2018 Aug 17, 2018	BUY	$50.53 - $62.98 $4.06 Million - $5.06 Million	80,400 Added 52.62%	233,200 $12.9 Million
Q1 2018 Apr 10, 2018	SELL	$59.92 - $68.98 $71,904 - $82,776	-1,200 Reduced 0.78%	152,800 $9.67 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $3.39 Million - $3.69 Million	56,500 Added 57.95%	154,000 $9.44 Million
Q3 2017 Oct 31, 2017	BUY	$55.23 - $63.74 $5.38 Million - $6.21 Million	97,500	97,500 $6.22 Million

Others Institutions Holding BMY

# of Institutions

2,425

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.93 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.87 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Andra Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Andra Ap Fonden with notifications on news.

Account